Gene therapy clinical trials are underway to treat one of the leading causes of blindness in the developed world.
The treatment for wet age-related macular degeneration (more advanced than dry macular degeneration) will hopefully be available to patients within three years, says the team at the Lions Eye Institute in Western Australia.
They’re using a modified virus to carry a gene into the cells at the back of the eye. The delivered gene encourages these cells to continuously secrete medication to treat the problem.